ARCHIVES

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions

November 18, 2011

Nexavar Improves PFS In HER-2 Negative Breast Cancer

May 27, 2011

Murphy Puts RPMI On Record

July 22, 1977

Cancer & The Media: Klausner, Watson Dispute Comments In New York Times Story

May 8, 1998

FDA Approves Abbott’s HER-2 DNA Probe Kit.

January 25, 2002

NCI Intramural Research: More Than 200 Scientists At Frederick To Become NCI Employees This Year

March 26, 1999